中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2013年
17期
406-407
,共2页
金黄色葡萄球菌%耐甲氧西林金黄色葡萄球菌%耐药性
金黃色葡萄毬菌%耐甲氧西林金黃色葡萄毬菌%耐藥性
금황색포도구균%내갑양서림금황색포도구균%내약성
Staphylococcus aureus%MRSA%Drug resistance
目的调查基层医院临床分离耐甲氧西林金黄色葡萄球菌(MRSA)成人与儿童感染现状及耐药谱,为临床医生合理使用抗生素,提供试验依据。方法对本院2011年1月至2012年10月间临床标本中检出的金黄色葡萄球菌鉴定和药敏试验结果进行回顾性分析。结果123株金黄色葡萄球菌中检出MRSA 67株,MRSA检出率为54.5%。成人与儿童MRSA感染率分别为58.7%与50.0%。MRSA耐药率明显高于甲氧西林敏感金黄色葡萄球菌(MSSA),未检出对万古霉素、替考拉宁及呋喃妥因耐药菌株。结论临床分离的金黄色葡萄球菌对常用抗菌药物呈多药耐药,尤其是MRSA耐药更严重,应根据分离菌株耐药特点选用不同的治疗方案,加强抗菌药物的合理使用,减少MRSA耐药性的发生。
目的調查基層醫院臨床分離耐甲氧西林金黃色葡萄毬菌(MRSA)成人與兒童感染現狀及耐藥譜,為臨床醫生閤理使用抗生素,提供試驗依據。方法對本院2011年1月至2012年10月間臨床標本中檢齣的金黃色葡萄毬菌鑒定和藥敏試驗結果進行迴顧性分析。結果123株金黃色葡萄毬菌中檢齣MRSA 67株,MRSA檢齣率為54.5%。成人與兒童MRSA感染率分彆為58.7%與50.0%。MRSA耐藥率明顯高于甲氧西林敏感金黃色葡萄毬菌(MSSA),未檢齣對萬古黴素、替攷拉寧及呋喃妥因耐藥菌株。結論臨床分離的金黃色葡萄毬菌對常用抗菌藥物呈多藥耐藥,尤其是MRSA耐藥更嚴重,應根據分離菌株耐藥特點選用不同的治療方案,加彊抗菌藥物的閤理使用,減少MRSA耐藥性的髮生。
목적조사기층의원림상분리내갑양서림금황색포도구균(MRSA)성인여인동감염현상급내약보,위림상의생합리사용항생소,제공시험의거。방법대본원2011년1월지2012년10월간림상표본중검출적금황색포도구균감정화약민시험결과진행회고성분석。결과123주금황색포도구균중검출MRSA 67주,MRSA검출솔위54.5%。성인여인동MRSA감염솔분별위58.7%여50.0%。MRSA내약솔명현고우갑양서림민감금황색포도구균(MSSA),미검출대만고매소、체고랍저급부남타인내약균주。결론림상분리적금황색포도구균대상용항균약물정다약내약,우기시MRSA내약경엄중,응근거분리균주내약특점선용불동적치료방안,가강항균약물적합리사용,감소MRSA내약성적발생。
Objective To investigate the clinic distribution and antibiotic resistance of methicillin resistant staphylococcus aureus(MRSA) in adult and children of primary hospital, providing experimental basis that clinical doctors use antibiotic correctly and efifciently. Methods A retrospective analysis was made on Staphylococcus aureus detected in our hospital from Jan 2011 to Oct 2012. Results Among 123 S.aureus isolatess, 67 MRSA isolates were detected, MRSA detection rate was 54.5%, in adult and children was 58.7%and 50.0%. MRSA drug-resistance rate was obviously higher than MSSA from the results of the susceptibility test. No detected isolates were resistant to vancomycin, teicoplanin and nitrofurantoin. Conclusion S.aureus isolated from clinic has multiple resistance to commonly used antimicrobial resistance, especially MRSA strains, different treatment protocols should be chosen according to the drug-resistant characteristics of isolated strains, we will strengthen the rational use of antibiotics to reduce the incidence of MRSA resistance.